{"transactions":[{"id":925551,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68237,"kind":"person","name":"Rivkin Anna","position":1,"cik":"0002035647","reported_name":"Rivkin Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-02T16:02:22.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":5.71,"value":942150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 30, 2027, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":165000,"derivative":{"exercise_price":5.71,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0002035647-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035647/000203564726000002/primarydocument.xml","form_type":"4"}},{"id":1295760,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68237,"kind":"person","name":"Rivkin Anna","position":1,"cik":"0002035647","reported_name":"Rivkin Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-24T16:11:43.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":4.37,"value":218500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on January 22, 2026, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter."}],"balance_after":50000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-25-000502","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035647/000156218025000502/primarydocument.xml","form_type":"4"}},{"id":1416237,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":68237,"kind":"person","name":"Rivkin Anna","position":1,"cik":"0002035647","reported_name":"Rivkin Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-09-04T16:02:47.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":7.85,"value":1491500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of common stock on September 3, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested."}],"balance_after":190000,"derivative":{"exercise_price":7.85,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001562180-24-006632","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035647/000156218024006632/primarydocument.xml","form_type":"4"}}]}